Adjuvant therapy for high-risk primary and resected metastatic melanoma.
about
CDH22 expression is reduced in metastatic melanoma.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8.Issues affecting molecular staging in the management of patients with melanomaPrognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesisUrban-rural differences in survival from cutaneous melanoma in Queensland.Role of ING4 in human melanoma cell migration, invasion and patient survival.Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control.Cancer immunotherapy: breaking the barriers to harvest the crop
P2860
Q35232266-B6200AE3-7976-4EFA-A9C5-AF9C613620FFQ35838744-55F0E3BA-D159-4C6E-8ED0-6F25BF906E1AQ36590676-A2BF6D34-552C-4EF9-982A-0697C53B21E7Q36990701-947E902B-FD38-43EB-BC56-F399F2CBCA43Q39721556-F209C4A8-2FDA-4912-849B-40737B48AF8EQ39747311-27B3CE02-D808-4F5C-A301-E5C4C272A34EQ39997072-5C6B00C4-5A56-4CD4-B42A-D89F1EABCED8Q40381577-1FF20F60-49E0-41EC-AF01-5330D133FAD1Q56888861-D5CDBC8F-507F-428E-8FB6-D848FF31CE0F
P2860
Adjuvant therapy for high-risk primary and resected metastatic melanoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Adjuvant therapy for high-risk primary and resected metastatic melanoma.
@en
type
label
Adjuvant therapy for high-risk primary and resected metastatic melanoma.
@en
prefLabel
Adjuvant therapy for high-risk primary and resected metastatic melanoma.
@en
P2860
P1476
Adjuvant therapy for high-risk primary and resected metastatic melanoma.
@en
P2093
P2860
P356
10.1046/J.1445-5994.2002.00289.X
P577
2003-01-01T00:00:00Z